Aug 8, 2023 | Cancer, Chronic conditions, Claims, Cost Savings, Heart, High-cost claims, MedBen WellLiving, Savings, Stop-Loss
Cancer and heart disease account for 37% of total stop-loss claim reimbursements over the past four years. This demonstrates once again the importance of a wellness program to catch chronic conditions, and reduce the risk of high-cost claims, at their earliest stages....
Jul 20, 2023 | Cancer, Chronic conditions, MedBen WellLiving, News, Survey, WellCare, Wellness, Wellness exam, Wellness screenings
A new Aflac Wellness Matters survey found that about 1 in 4 employed adults in the U.S. skip regular checkups because they feel healthy, don’t have the time, or don’t like going to the doctor (among other reasons cited). Also, nearly half of adults said...
Mar 2, 2023 | Asthma, Cancer, Cholesterol, Cost Savings, Diabetes, Heart, MedBen WellLiving, News, Preventive Care, Primary Care, Reporting, Savings
A new report finds that the primary care workforce has decreased in recent years, and advises that the U.S. should invest more in adding new physicians. It’s a sensible suggestion, considering that primary care has demonstrably contributed to making Americans...
Feb 16, 2023 | Cancer, MedBen WellLiving, Preventive Care, Research, Wellness, Wellness exam
Prevention and early detection have contributed to a three-decade decline in cancer mortality, a new report from the American Cancer Society (ACS) finds. With an increased emphasis on being proactive about wellness exams and cancer screenings, the U.S. cancer death...
Jul 26, 2022 | Cancer, Claims, COVID-19, Heart, Mental Health, Stop-Loss
Cancer and cardiovascular conditions account for over one-third of stop-loss reimbursements, according to a recent report from stop-loss carrier Sun Life.As the chart below shows, the top three conditions represent 38% of total payments. Additionally, 70% of all...
Nov 26, 2021 | Cancer, Cost Savings, MedBen WellLiving, Preventive Care, Savings
Care for the 15 most prevalent types of cancer in the United States cost approximately $156.2 billion in 2018, a new study finds. Drugs for breast, lung, lymphoma and colorectal cancers incurred the highest costs. “Cancer is … actually overtaking heart disease as the...
